AGORA Cancer Research Center
AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).
Latest news
Events
![](https://agora-cancer.ch/wp-content/uploads/2024/07/Image1-3.png)
AGORA BBQ | August 22nd
Events
![](https://agora-cancer.ch/wp-content/uploads/2023/05/Agora_PhD_Logo-1024x888.png)
PhD Thesis Defense | July 19th
Events
![](https://agora-cancer.ch/wp-content/uploads/2022/12/image-1-1024x375.jpg)
AGORA Tumor Microenvironment Journal Club
Latest publications
Investigation of a fluorescent reporter microenvironment niche labeling strategy in experimental brain metastasis
Massara M, Dolfi B, Wischnewski V, (…), Held W, Malanchi I, Joyce JA
iScience – 2024 Jul 19
Cryoablation does not significantly contribute to systemic effector immune responses in poorly immunogenic B16F10 melanoma model.
Yakkala C, Corria-Osorio J, Kandalaft L, (…), Denys A, Koppolu B, Duran R
Clinical cancer research : an official journal of the American Association for Cancer Research – 2024 Jul 18
Preclinical SPECT and PET: Joint EANM and ESMI procedure guideline for implementing an efficient quality control programme.
Vanhove C, Koole M, Fragoso Costa P, (…), McDougald W, Tavares A, Bernsen M
European journal of nuclear medicine and molecular imaging – 2024 Jul 15
Patient-derived mini-colons enable long-term modeling of tumor-microenvironment complexity.
Lorenzo-Martín LF, Broguiere N, Langer J, (…), Coukos G, Homicsko K, Lutolf MP
Nature biotechnology – 2024 Jul 2
Expression of Concern: Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity.
Hong A, Piva M, Liu S, (…), Ribas A, Moriceau G, Lo RS
Cancer discovery – 2024 Jul 1